| 000 | 01629 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517181801.0 | ||
| 264 | 0 | _c20171227 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1545-5017 | ||
| 024 | 7 |
_a10.1002/pbc.26855 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPillon, Marta | |
| 245 | 0 | 0 |
_aPrimary mediastinal large B-cell lymphoma: Outcome of a series of pediatric patients treated with high-dose methotrexate and cytarabine plus anti-CD20. _h[electronic resource] |
| 260 |
_bPediatric blood & cancer _cFeb 2018 |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMediastinal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aRituximab _xadministration & dosage |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aCarraro, E | |
| 700 | 1 | _aMussolin, L | |
| 700 | 1 | _aConter, V | |
| 700 | 1 | _aTondo, A | |
| 700 | 1 | _aAricò, M | |
| 700 | 1 | _aMura, R | |
| 700 | 1 | _aSala, A | |
| 700 | 1 | _aVinti, L | |
| 700 | 1 | _aBuffardi, S | |
| 700 | 1 | _aPierani, P | |
| 700 | 1 | _ad'Amore, E S G | |
| 700 | 1 | _aBasso, G | |
| 773 | 0 |
_tPediatric blood & cancer _gvol. 65 _gno. 2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/pbc.26855 _zAvailable from publisher's website |
| 999 |
_c27702283 _d27702283 |
||